Erlosamide
Back to searchMolecule Structure
Scientific Name
Erlosamide
Description of the Drug
Lacosamide is an antiepileptic drug used to treat partial onset seizures in adults.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB06218
http://www.drugbank.ca/drugs/DB06218
Brand Name(s)
Lacosamide, Vimpat
Company Owner(s)
Alkem Laboratories Ltd, Mylan Pharmaceuticals Inc, Amneal Pharmaceuticals Of New York Llc, Zydus Pharmaceuticals Usa Inc, Novitium Pharma Llc, Indoco Remedies Ltd, Fresenius Kabi Usa Llc, Accord Healthcare Inc, Amneal Pharmaceuticals, Aurobindo Pharma Ltd
Mechanism(s) Of Action
| Target Name | Target Type | Action Type | Target ChEMBL ID |
|---|---|---|---|
| Sodium channel alpha subunit | PROTEIN FAMILY | BLOCKER | CHEMBL2331043 |
Clinical Trial(s)
Unichem Links
| SureChEMBL | SCHEMBL35330 | |
| PharmGKB | PA166160048 | |
| DrugBank | DB06218 | |
| PubChem: Thomson Pharma | 15196715 | 14847708 |
| PubChem | 219078 | |
| Mcule | MCULE-8848296606 | |
| LINCS | LSM-45385 | |
| Nikkaji | J1.029.117H | |
| BindingDB | 50300204 | |
| EPA CompTox Dashboard | DTXSID1057666 | |
| DrugCentral | 4310 | |
| ChemicalBook | CB41011740 | |
| Guide to Pharmacology | 7472 | |
| rxnorm | VIMPAT | LACOSAMIDE |
| PubChem: Drugs of the Future | 12015335 | |
| ChEBI | 135939 | |
| ZINC | ZINC000000007673 |
